NCT05558137View on ClinicalTrials.gov

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

May 22, 2023

Study Completion Date

May 25, 2023

Conditions
Onset Time of Mivacurium, Duration of Action of Mivacurium
Interventions
DRUG

Mivacurium

0.2 mg/kg based on ideal body weight calculated as height (cm) minus 105 for women and height (cm) minus 100 for men or actual body weight, whichever is lower

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Matias Vested

OTHER